Results 221 to 230 of about 1,512,475 (325)

Coronary Artery Disease and Axillary Lymphadenopathy Post COVID-19 Vaccine Administration: Insights from Tl-201 Myocardial Perfusion Imaging. [PDF]

In Vivo
Chen TY, Tseng TC, Shen DH, Shiue YL, Yang JH, Chan HP.   +5 more
europepmc   +1 more source

Ílhavo na Época Moderna [PDF]

, 2017
Ribeiro, Ana Isabel
core  

Technologies of the Self and the Body in Octavio Paz\u27s The Works of the Poet [PDF]

, 2007
Chavez, Daniel
core   +2 more sources

The post-pandemic pivot: mRNA therapeutics enter the chronic rare disease arena. [PDF]

Mol Ther Nucleic Acids
Giangrande PH.
europepmc   +1 more source

Classicismes en l'arquitectura moderna [PDF]

, 1982
Solà-Morales i Rubió, Ignasi de
core  

A Response to: Letter to the Editor Regarding “Real-World Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 on Inpatient and Medically Attended COVID-19 Among Immunocompromised US Adults”

Infectious Diseases and Therapy
Mihaela Georgieva, Tianyu Sun, Ekkehard Beck   +2 more
doaj   +1 more source

Il·luminació moderna de ciutats [PDF]

, 2014
David B. Aloy
core   +1 more source

Malaga Moderna: the role of planning and morphological change in changing the image of the city, 1880-1936 [PDF]

, 2011
Barke, Mike
core  

Phase 1/2 randomized, observer-blind clinical trial of a first-generation, mRNA-based vaccine against seasonal influenza and COVID-19 in healthy adults. [PDF]

Hum Vaccin Immunother
Rudman Spergel AK, Henry C, Nachbagauer R, Kaplonek P, Astley E, Avanesov A, Bertera H, Carmona L, Cizmeci D, Collins A, Embry A, Guo R, Mao X, Pucci A, Shao S, Shih-Lu-Lee J, Yu WH, Brune D, Chu L, Irfan M, Alter G, Ananworanich J, Shaw CA.   +22 more
europepmc   +1 more source

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances. [PDF]

Vaccine
Heng F, Magaret CA, Rouphael NG, Branche AR, Fong Y, Carpp LN, Yu C, Chen S, Zhang B, Diemert DJ, Falsey AR, Graciaa DS, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Simon V, van Bakel H, Roberts PC, Gilbert PB, Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team.   +41 more
europepmc   +1 more source